Global Aptamers 麻豆原创 Research Report 2024

Publication ID:

PB502243324

Publication Date:

February 26, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Aptamers are high affinity molecules that are derived from RNA or DNA. These are normally generated using a synthetic process called 鈥淪ystematic evolution of ligands by exponential enrichment鈥� (SELEX).
Aptamers receive their name from the Latin word aptus meaning 鈥渇it鈥�. This means they bind to the target molecules with high specificity and high affinity.
Aptamers are short nucleic acids that interact with a variety of targets with high affinity and specificity. They have been shown to inhibit biological functions of cognate target proteins, and they are identifiable by an in vitro selection process, also termed SELEX (Systematic Evolution of Ligands by EXponential enrichment). Being nucleic acids, aptamers can be synthesized chemically or enzymatically.
The global Aptamers market was valued at US$ 245.2 million in 2023 and is anticipated to reach US$ 829.2 million by 2030, witnessing a CAGR of 19.0% during the forecast period 2024-2030.
Global Aptamers key players include TriLink BioTechnologies, SomaLogic, AM Biotechnologies, Aptamer Sciences, Base Pair Biotechnologies etc. The Global top 10 manufacturers hold a share about 14%.North America is the largest market, with a share about 45%, followed by Europe and Asia Pacific with the share about 30% and 22%.
This report aims to provide a comprehensive presentation of the global market for Aptamers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aptamers.
Report Scope
The Aptamers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aptamers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aptamers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
TriLink BioTechnologies
AptaBharat
SomaLogic
AM Biotechnologies
Aptamer Sciences
Base Pair Biotechnologies
Aptamer Group
Aptagen
Aptus Biotech
NeoVentures Biotechnology
Ray Biotech
Vivonics
Segment by Type
DNA-Based Aptamers
RNA-Based Aptamers
Segment by Application
Research and Development
Drug Discovery
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aptamers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aptamers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Aptamers 麻豆原创 Overview
1.1 Product Overview and Scope of Aptamers
1.2 Aptamers Segment by Type
1.2.1 Global Aptamers 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 DNA-Based Aptamers
1.2.3 RNA-Based Aptamers
1.3 Aptamers Segment by Application
1.3.1 Global Aptamers 麻豆原创 Value by Application: (2024-2030)
1.3.2 Research and Development
1.3.3 Drug Discovery
1.4 Global Aptamers 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Aptamers Revenue 2019-2030
1.4.2 Global Aptamers Sales 2019-2030
1.4.3 Global Aptamers 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Aptamers 麻豆原创 Competition by Manufacturers
2.1 Global Aptamers Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Aptamers Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Aptamers Average Price by Manufacturers (2019-2024)
2.4 Global Aptamers Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Aptamers, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aptamers, Product Type & Application
2.7 Aptamers 麻豆原创 Competitive Situation and Trends
2.7.1 Aptamers 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Aptamers Players 麻豆原创 Share by Revenue
2.7.3 Global Aptamers 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Aptamers Retrospective 麻豆原创 Scenario by Region
3.1 Global Aptamers 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Aptamers Global Aptamers Sales by Region: 2019-2030
3.2.1 Global Aptamers Sales by Region: 2019-2024
3.2.2 Global Aptamers Sales by Region: 2025-2030
3.3 Global Aptamers Global Aptamers Revenue by Region: 2019-2030
3.3.1 Global Aptamers Revenue by Region: 2019-2024
3.3.2 Global Aptamers Revenue by Region: 2025-2030
3.4 North America Aptamers 麻豆原创 Facts & Figures by Country
3.4.1 North America Aptamers 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Aptamers Sales by Country (2019-2030)
3.4.3 North America Aptamers Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Aptamers 麻豆原创 Facts & Figures by Country
3.5.1 Europe Aptamers 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Aptamers Sales by Country (2019-2030)
3.5.3 Europe Aptamers Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aptamers 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Aptamers 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Aptamers Sales by Country (2019-2030)
3.6.3 Asia Pacific Aptamers Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Aptamers 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Aptamers 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Aptamers Sales by Country (2019-2030)
3.7.3 Latin America Aptamers Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aptamers 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Aptamers 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Aptamers Sales by Country (2019-2030)
3.8.3 Middle East and Africa Aptamers Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Aptamers Sales by Type (2019-2030)
4.1.1 Global Aptamers Sales by Type (2019-2024)
4.1.2 Global Aptamers Sales by Type (2025-2030)
4.1.3 Global Aptamers Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Aptamers Revenue by Type (2019-2030)
4.2.1 Global Aptamers Revenue by Type (2019-2024)
4.2.2 Global Aptamers Revenue by Type (2025-2030)
4.2.3 Global Aptamers Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Aptamers Price by Type (2019-2030)
5 Segment by Application
5.1 Global Aptamers Sales by Application (2019-2030)
5.1.1 Global Aptamers Sales by Application (2019-2024)
5.1.2 Global Aptamers Sales by Application (2025-2030)
5.1.3 Global Aptamers Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Aptamers Revenue by Application (2019-2030)
5.2.1 Global Aptamers Revenue by Application (2019-2024)
5.2.2 Global Aptamers Revenue by Application (2025-2030)
5.2.3 Global Aptamers Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Aptamers Price by Application (2019-2030)
6 Key Companies Profiled
6.1 TriLink BioTechnologies
6.1.1 TriLink BioTechnologies Corporation Information
6.1.2 TriLink BioTechnologies Description and Business Overview
6.1.3 TriLink BioTechnologies Aptamers Sales, Revenue and Gross Margin (2019-2024)
6.1.4 TriLink BioTechnologies Aptamers Product Portfolio
6.1.5 TriLink BioTechnologies Recent Developments/Updates
6.2 AptaBharat
6.2.1 AptaBharat Corporation Information
6.2.2 AptaBharat Description and Business Overview
6.2.3 AptaBharat Aptamers Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AptaBharat Aptamers Product Portfolio
6.2.5 AptaBharat Recent Developments/Updates
6.3 SomaLogic
6.3.1 SomaLogic Corporation Information
6.3.2 SomaLogic Description and Business Overview
6.3.3 SomaLogic Aptamers Sales, Revenue and Gross Margin (2019-2024)
6.3.4 SomaLogic Aptamers Product Portfolio
6.3.5 SomaLogic Recent Developments/Updates
6.4 AM Biotechnologies
6.4.1 AM Biotechnologies Corporation Information
6.4.2 AM Biotechnologies Description and Business Overview
6.4.3 AM Biotechnologies Aptamers Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AM Biotechnologies Aptamers Product Portfolio
6.4.5 AM Biotechnologies Recent Developments/Updates
6.5 Aptamer Sciences
6.5.1 Aptamer Sciences Corporation Information
6.5.2 Aptamer Sciences Description and Business Overview
6.5.3 Aptamer Sciences Aptamers Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aptamer Sciences Aptamers Product Portfolio
6.5.5 Aptamer Sciences Recent Developments/Updates
6.6 Base Pair Biotechnologies
6.6.1 Base Pair Biotechnologies Corporation Information
6.6.2 Base Pair Biotechnologies Description and Business Overview
6.6.3 Base Pair Biotechnologies Aptamers Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Base Pair Biotechnologies Aptamers Product Portfolio
6.6.5 Base Pair Biotechnologies Recent Developments/Updates
6.7 Aptamer Group
6.6.1 Aptamer Group Corporation Information
6.6.2 Aptamer Group Description and Business Overview
6.6.3 Aptamer Group Aptamers Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aptamer Group Aptamers Product Portfolio
6.7.5 Aptamer Group Recent Developments/Updates
6.8 Aptagen
6.8.1 Aptagen Corporation Information
6.8.2 Aptagen Description and Business Overview
6.8.3 Aptagen Aptamers Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Aptagen Aptamers Product Portfolio
6.8.5 Aptagen Recent Developments/Updates
6.9 Aptus Biotech
6.9.1 Aptus Biotech Corporation Information
6.9.2 Aptus Biotech Description and Business Overview
6.9.3 Aptus Biotech Aptamers Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Aptus Biotech Aptamers Product Portfolio
6.9.5 Aptus Biotech Recent Developments/Updates
6.10 NeoVentures Biotechnology
6.10.1 NeoVentures Biotechnology Corporation Information
6.10.2 NeoVentures Biotechnology Description and Business Overview
6.10.3 NeoVentures Biotechnology Aptamers Sales, Revenue and Gross Margin (2019-2024)
6.10.4 NeoVentures Biotechnology Aptamers Product Portfolio
6.10.5 NeoVentures Biotechnology Recent Developments/Updates
6.11 Ray Biotech
6.11.1 Ray Biotech Corporation Information
6.11.2 Ray Biotech Aptamers Description and Business Overview
6.11.3 Ray Biotech Aptamers Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Ray Biotech Aptamers Product Portfolio
6.11.5 Ray Biotech Recent Developments/Updates
6.12 Vivonics
6.12.1 Vivonics Corporation Information
6.12.2 Vivonics Aptamers Description and Business Overview
6.12.3 Vivonics Aptamers Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Vivonics Aptamers Product Portfolio
6.12.5 Vivonics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aptamers Industry Chain Analysis
7.2 Aptamers Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aptamers Production Mode & Process
7.4 Aptamers Sales and 麻豆原创ing
7.4.1 Aptamers Sales Channels
7.4.2 Aptamers Distributors
7.5 Aptamers Customers
8 Aptamers 麻豆原创 Dynamics
8.1 Aptamers Industry Trends
8.2 Aptamers 麻豆原创 Drivers
8.3 Aptamers 麻豆原创 Challenges
8.4 Aptamers 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

TriLink BioTechnologies
AptaBharat
SomaLogic
AM Biotechnologies
Aptamer Sciences
Base Pair Biotechnologies
Aptamer Group
Aptagen
Aptus Biotech
NeoVentures Biotechnology
Ray Biotech
Vivonics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.